Your Search for 'Type 2 Diabetes - Pipeline Assessment and Market Forecasts to 2017' returned 17 results - Page 1 of 1

• Diabetes Care Devices Market to 2017 - Artificial Pancreas to Be the Key Technology Driver for the Market

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GBI Research, Apr 2011 , Pages: 70
  - Country Analysis and Forecasts 23 6.1 Historic (2003–2010) and Forecast (2010-2017) Revenue, by Country 24 6.1.1 Diabetes Care Devices Market, the US, Revenue Historic ($m), 2003 – 2010 24 6.1.2 Diabetes ...

• Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GBI Research, Mar 2012 , Pages: 72
  ). - Annualized market revenues data, forecast forward for seven years to 2017. Company shares data for 2010. - Qualitative analysis of key market trends for diabetes care devices imaging equipment in emerging ...

• ASP1941 (Type 2 Diabetes) - Analysis and Forecasts to 2020

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 GlobalData, Jan 2012 , Pages: 42
  , Type 2 Diabetes, Diabetes, Sales Forecasts, Sodium-Glucose coTransporter 2 (SGLT2), Phase III, Phase 3, Pipeline, Competitors to ASP1941 - Lantus, Onglyza, Januvia, Janumet and Victoza, Astellas Pharma ...

• Aleglitazar (Type 2 Diabetes) - Analysis and Forecasts to 2020

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 GlobalData, Jan 2012 , Pages: 40
  Aleglitazar, Type 2 Diabetes, Diabetes, R1439, Sales Forecasts, Thiazolidinedione (TZD), Phase III, Phase 3, Pipeline, Competitors to Aleglitazar - Lantus, Onglyza, Januvia, Janumet and Victoza, Hoffman la ...

• Amaryl (Type 2 Diabetes) - Analysis and Forecasts to 2020

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 GlobalData, Jan 2012 , Pages: 44
  Amaryl (Type 2 Diabetes) - Analysis and Forecasts to 2020 Amaryl (Type 2 Diabetes) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Amaryl (Type 2 Diabetes) – Analysis ...

• Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GlobalData, Dec 2011 , Pages: 88
  Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary ...

• Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

  EURO€ 3,071.00USD$ 3,995.00GBP£ 2,584.00AUD$ 3,907.00JPY¥ 394,438.00SEK 26 231,00CHF 3'765.00CAD$ 4,071.00 GlobalData, Jan 2012 , Pages: 85
  Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Blood Glucose Monitoring Devices (Meters, Test Strips ...

• Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

  EURO€ 3,071.00USD$ 3,995.00GBP£ 2,584.00AUD$ 3,907.00JPY¥ 394,438.00SEK 26 231,00CHF 3'765.00CAD$ 4,071.00 GlobalData, Jan 2012 , Pages: 104
  Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts ...

• Cardiovascular Devices Market to 2017 - Minimally Invasive Techniques and Cardiac Prosthetic Devices to Drive Future Growth

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GBI Research, Feb 2012 , Pages: 213
  Dynamics 74 5 Global Cardiovascular Devices Market - Country Analysis and Forecasts 75 5.1 Cardiovascular Devices Market - Cross-Country Analysis 75 5.2 Historic (2003-2010) and Forecast (2010-2017) Revenue ...

• Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

  EURO€ 3,071.00USD$ 3,995.00GBP£ 2,584.00AUD$ 3,907.00JPY¥ 394,438.00SEK 26 231,00CHF 3'765.00CAD$ 4,071.00 GlobalData, Jan 2012 , Pages: 90
  Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis ...

• Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GlobalData, Jan 2012 , Pages: 91
  Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts ...

• Ophthalmic Diagnostic Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GlobalData, Oct 2011 , Pages: 114
  Ophthalmic Diagnostic Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Ophthalmic Diagnostic Equipment - Global Pipeline Analysis, Competitive Landscape and ...

• North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GlobalData, Dec 2011 , Pages: 106
  North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery ...

• The World Market for Gynaecology, 2007-2017

  EURO€ 4,800.00USD$ 5,424.00GBP£ 3,200.00AUD$ 7,500.00JPY¥ 650,407.00SEK 42 667,00CHF 7'143.00CAD$ 6,957.00 Spectra Intelligence, Sep 2007 , Pages: 350
  gynaecological prescription products with therapy area and sales forecasts to 2017; - Analysis of market dynamics for infertility, contraception, menstrual and gynaecological disorders, and menopause; - Product ...

• Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GlobalData, Oct 2011 , Pages: 108
  Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Pacemakers and Cardiac Resynchronization Therapy ...

• Top 10 Healthcare Trends in 2011

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GBI Research, Mar 2011 , Pages: 194
  type, geography and companies - Analysis of M&A deals in 2010 along with segmentation by value geography and companies Reasons to buy - Develop market-entry and market expansion strategies by ...

• Cardiovascular Disease Diagnostics - Global Strategic Business Report

  EURO€ 3,982.00USD$ 4,500.00GBP£ 2,655.00AUD$ 6,223.00JPY¥ 539,634.00SEK 35 400,00CHF 5'926.00CAD$ 5,772.00 Global Industry Analysts, Inc, Apr 2012 , Pages: 498
  Segments: In Vitro Diagnostics, and In Vivo Diagnostics. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The ...